Cambridge University Press
  • Welcome Guest user
  • Log in | Register
 
Athens log in
Username Password  
Forgot your password?
Subscribe now to view full content , or if you already have an account,
please Login to access this feature
Subscribe now to view full content, or if you already have an account,
please Login to access this feature
Subscribe now to access this feature, or if you already have an account,
please Login.
 
 
  • Advanced search
Cambridge University Press logo
Stahl's Essential Psychopharmacology Online
In Collaboration With NEI
Stahl's Essential Psychopharmacology

Navigation

  • Home
  • The
    Prescriber's Guide
  • Essential
    Psychopharmacology
  • Essential
    Neuropharmacology
  • Other
    Resources
    • Next Generation Antidepressants:
      Beyer and Stahl
  • Stahl's
    Illustrated
  • Drug
    Interaction
 
  • My Bookmarks
  • TOC

Table of Contents

Introduction

List of Icons

A

acetazolamide almotriptan alteplase amantadine
amitriptyline apomorphine armodafinil aspirin (acetylsalicylic acid)
azathioprine      

B

baclofen benztropine botulinum toxin type A botulinum toxin type B
bromocriptine      

C

carbamazepine carbidopa/levodopa carisoprodol chlorpromazine
clonazepam clonidine clopidogrel clozapine
cyclobenzaprine cyclophosphamide cyclosporine cyproheptadine

D

dantrolene 3,4-diaminopyridine diazepam dihydroergotamine (Dhe)
dipyridamole and aspirin donepezil droperidol duloxetine

E

edrophonium eletriptan entacapone ethosuximide

F

felbamate flunarizine fluoxetine frovatriptan

G

gabapentin galantamine glatiramer acetate guanfacine
guanidine hydrochloride      

H

haloperidol heparin    

I

immune globulin intravenous (IGIV) indomethacin interferon-beta  

L

lacosamide lamotrigine levetiracetam lithium

M

mannitol meclizine memantine metaxalone
methocarbamol methotrexate methylergonovine methysergide
metoclopramide mexiletine mitoxantrone modafinil
mycophenolate mofetil      

N

naratriptan natalizumab nimodipine nortriptyline

O

oxcarbazepine    

P

penicillamine phenobarbital phenytoin pizotifen
pramipexole prednisone pregabalin primidone
prochlorperazine propranolol pyridostigmine  

Q

quetiapine quinine sulfate    

R

rasagiline reserpine riluzole rituximab
rivastigmine rizatriptan ropinirole rufinamide

S

selegiline sumatriptan    

T

tetrabenazine tiagabine timolol tizanidine
topiramate trientine hydrochloride trihexyphenidyl  

V

valproic acid venlafaxine verapamil vigabatrin

W

warfarin      

Z

zolmitriptan zonisamide    

Index by drug name (generic and international trade names)

Index by use

Index by class

Abbreviations

 

Current Prices for Individual Subscribers (prices are subject to change)

  Pay-per-view Subscription (48 hours) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 3rd Edition

ISBN: 9780511447990


$ 40
  Annual Subscription (Single User) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 3rd Edition

ISBN: 9780511447983


$ 195
  Print + Online Access (One Year, Single User) Unit price

Purchase

Stahl's Essential Psychopharmacology Online

Digital Edition: Print and Online

Once you are sent the Digital Edition, just enter the code from the inside back cover to activate your one-year access to www.stahlonline.org.

ISBN: 9780521746090


$261
For pricing and information for Academic and Medical Libraries, Corporate, Nonprofit or Government Institutions and/or special sales or website sponsorship,

for the Americas please contact:
Cambridge Library Sales,
stahlonline@cambridge.org,
800-221-4512, x6535.

For the rest of the world, please contact:
academicsales@cambridge.org
or call +44 (0) 1223 325741.

Australia and New Zealand
Phone: +61 (3) 8671 1400,
Fax: +61 3 9676 9966,
Email: enquiries@cambridge.edu.au.

 

Footer links

  • About Cambridge University Press
  • About NEI
  • About Dr. Stahl
  • About the Illustrator
  • © Cambridge University Press 2008.
  • Copyright statement
  • Privacy Policy
  • Accessibility
  • Terms of use
  • FAQ
  • Help
  • View Access Details
  • Contact us